• Service
  • Resources
    • Webinars
    • Upcoming Events
    • Documents Download
    • FAQ
    • NMPA Approval Report
  • News
  • CER
  • About
Subscribe

Our Services

Strategy Consulting

  • Market Entry Strategy
  • Regulatory Strategy
  • Clinical Strategy
  • China Localization Strategy
  • Hainan Urgent Use Pathway
  • Innovation Pathway
  • Fast Track Pathway
  • Digital Health Consulting

Registration Affairs

  • Pre-market Registration
  • Modification Registration
  • Renewal Registration
  • Request for Classification
  • Legal Agent Representation
  • NMPA Expert Panel Meeting
  • NMPA Supplemental Notice

Quality Assurance

  • Postmarket Surveillance Compliance (IFU, Label, GSP)
  • Adverse Event Reporting
  • Recall Handling
  • Periodic Risk Evaluation Report
  • Annual QMS Self-Inspection Report
  • NMPA Inspections & Mock-Audit
  • QMS Establishment/Audit/Remediation
  • QA Gap Analysis
  • Factory Audit
  • Unique Device Identifier

Device Testing

  • China Local Type Testing
  • Device Modification Compliance Testing
  • Biocompatibility Testing
  • EMC Testing

Clinical Research Organization (CRO)

  • Clinical Trials/Research
  • Real-World Study
  • China CER & MDR CER
  • Clinical Evaluation Feasibility Assessment

Customized Training

  • China Regulatory Training
  • China QMS Training
  • China GCP Training
  • China Localization Training
  • Periodic Regulatory Updates Training

Other Services

  • Translation
  • Patent & Trademark
  • Distributor Evaluation & Audit
  • KOL Interview/Consultation
  • Investment
  • Global regulatory services
  • Service
  • Resources
    • Resources
    • Webinars
    • Upcoming Events
    • Documents Download
    • FAQ
    • NMPA Approval Report
  • News
  • About
  • CER
  • Subscribe
  • CN
  • US
  • Home
  • QMS&PMS
  • Webinars

Webinars


  • Webinars
  • Revisiting Order 739
  • Order 739
  • Clinical Evaluation
  • QMS&PMS
  • Respiratory Registration
  • China GMP/GSP/NMPA Onsite Inspections
  • Short Videos
  • China Localization

Part 4 Responsibilities And Potential Risks Of Medical Device License Holder In PMS.

2021-10-01

This session of the webinar introduces the the responsibilities and potential risks of medical device license holder in…

READ MORE >

Part 3 Medical Device Product Life Cycle Management With A Focus On Design Control

2021-10-01

This session of the webinar introduces the Medical device product life cycle management with a focus on design…

READ MORE >

Part 2 NMPA Medical Device QMS/GMP And Its Alignment With International Regulations Or Standards.

2021-10-01

This session of the webinar introduces the medical device QMS/GMP and its alignment with international regulations or standards.…

READ MORE >

Part 1 NMPA Medical Device Regulations/guidelines And Major Updates

2021-10-01

This session of the webinar introduces the medical device regulations/ guidelines and major updates. The speaker introduces the…

READ MORE >

Part 8 Takeaways

2021-10-01

This session of the webinar introduces takeaways. The speaker labeled in following points: clinical evaluation shall be conducted…

READ MORE >

Part 7 Other Updates Relevant To Clinical Evaluation

2021-10-01

This session of the webinar introduces other updates relevant to clinical evaluation. The speaker talk about the technical…

READ MORE >

Part 6 Major Differences Between China CER And MDR CER

2021-10-01

This session of the webinar introduces major differences between China CER and MDR CER. The speaker use table…

READ MORE >

Part 5 How To Write A China CER Under The New Regulation

2021-10-01

This session of the webinar introduces how to write a China CER under the new regulation. Firstly, the…

READ MORE >

Part 4 When Can You Submit A CER In Lieu Of A CSR

2021-10-01

This session of the webinar introduces when can you submit a CER in lieu of a CSR. Firstly,…

READ MORE >

Part 3 Are Your Devices Clinical Exempted

2021-10-01

This session of the webinar introduces medical device exempted from clinical trail. It explains some exemption criteria, consolidated…

READ MORE >

Part 2 Major Changes To Clinical Evaluation Under Order 739

2021-10-01

This session of the webinar introduces major changes to clinical evaluation under order 739. it has some differences…

READ MORE >

Part 1 Order 739 Background

2021-10-01

This session of the webinar introduces medical device regulation milestones in China which is from 2014-2021. Then it…

READ MORE >

Prev12345Next
Twitter Linkedin
United States
Email: info@bradyknowsmedical.com
Phone: +86 18600392020
China
Beijing Office: Room 1501-1502, East Ocean Centre, No. 24 A, Jianguomenwai Avenue, Chaoyang District, Beijing, China
Shanghai Office: Lingang New Zone, China (Shanghai) Pilot Free Trade Zone
Hainan Office: Boao Lecheng pilot zone of international medical tourism, Qionghai City, Hainan Province
Email: info@bradyknowsmedical.com
Phone: +86 18600392020 +86 10 65155991

©2025 Bradynuoen Beijing PharmTech Co Ltd All Rights Reserved.

京ICP备15042665号-7